NCT00347048View on ClinicalTrials.gov

Tacrolimus (FK506) Study in Moderate to Severe Refractory Ulcerative Colitis Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

April 30, 2008

Study Completion Date

April 30, 2008

Conditions
Ulcerative Colitis
Interventions
DRUG

tacrolimus

oral

DRUG

Placebo

oral

Trial Locations (6)

Unknown

Chubu Region

Hokkaido Region

Kansai Region

Kanto Region

Kyushu Region

Shin'etsu Region

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY

NCT00347048 - Tacrolimus (FK506) Study in Moderate to Severe Refractory Ulcerative Colitis Patients | Biotech Hunter | Biotech Hunter